Minutes published of UK NSC March 2026 meeting
The UK NSC has published the minutes of its March 2026 meeting, including an updated prostate cancer screening recommendation.
Mike Harris
Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
UK NSC stakeholder engagement strategy updated
UK NSC stakeholder engagement strategy updated after comprehensive review.
Minutes published of UK NSC November 2025 meeting
The minutes have been published of the UK NSC November 2025 meeting.
UK NSC opens consultation on draft prostate cancer screening recommendation
The UK NSC has opened a public consultation on the evidence relating to screening for prostate cancer.
Consultation opens on antenatal and newborn screening for fragile X syndrome
The UK NSC has opened a consultation on the evidence relating to antenatal and newborn screening for Fragile X syndrome.
Exciting opportunities to join UK NSC expert groups
The UK NSC has 15 vacancies to fill on 3 of its expert advisory groups.
UK NSC consults on extending the in-service evaluation of screening for SCID
Posted by:
Mike Harris, Posted on:
-
Categories:
Newborn Blood Spot Screening, UK National Screening Committee
The UK National Screening Committee has opened a consultation on a recommendation to continue the in-service evaluation of newborn screening for SCID in NHS services.
UK NSC stakeholder discussion groups: could you help?
Would you like to be involved in a UK NSC stakeholder focus group?
Nearly 200 people respond to UK NSC stakeholder survey
Many thanks to everyone who responded to the UK NSC stakeholder survey. We will analyse the results and use them to inform any changes needed to the UK NSC stakeholder engagement strategy and activities.
New NIHR evidence synthesis groups give major boost to the UK NSC
The National Institute for Health Research is investing millions of pounds to provide the UK NSC with dedicated research expertise.